Botswana

• 

  Subject Areas on Research

  • AIDS is your business. 
  • AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial. 
  • Association of respiratory viruses with outcomes of severe childhood pneumonia in Botswana. 
  • Comparative analyses of clinical and environmental populations of Cryptococcus neoformans in Botswana. 
  • Effect of Haemophilus influenzae Type b and 13-Valent Pneumococcal Conjugate Vaccines on Childhood Pneumonia Hospitalizations and Deaths in Botswana. 
  • Evidence of sexual recombination among Cryptococcus neoformans serotype A isolates in sub-Saharan Africa. 
  • Interpretation of pediatric chest radiographs by non-radiologist clinicians in Botswana using World Health Organization criteria for endpoint pneumonia. 
  • Investigating Mediators of the Poor Pneumonia Outcomes of Human Immunodeficiency Virus-Exposed but Uninfected Children. 
  • Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. 
  • Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting. 
  • Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana. 
  • Predictors of Poor Outcomes Among Infants With Respiratory Syncytial Virus-associated Acute Lower Respiratory Infection in Botswana. 
  • Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. 
  • Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial. 
  • The Nasopharyngeal Microbiota of Children With Respiratory Infections in Botswana. 
  • The cost of HIV/AIDS to businesses in southern Africa. 
  • The demographic transition in southern Africa: another look at the evidence from Botswana and Zimbabwe. 
  • The demographic transition in southern Africa: reviewing the evidence from Botswana and Zimbabwe. 
  • The effect of exposure to wood smoke on outcomes of childhood pneumonia in Botswana. 
  • The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana. 
  • Treatment Failures and Excess Mortality Among HIV-Exposed, Uninfected Children With Pneumonia. 
  • Validation of the surveillance system for tuberculosis in Botswana.